Benitec Biopharma Limited announced that Gregory R. Reyes has joined the company as Senior Scientific Advisor. As the Senior Scientific Advisor, Dr. Reyes will lead the company's efforts to advance and expand its portfolio of gene therapy products. His leadership and vision will be integral to the achievement of the operational and strategic goals regarding the Company's key indications and research programs. Dr. Reyes will also oversee the expansion of the Company's scientific operations to facilitate the successful execution of the Company's broad based research collaboration with Axovant, comprising five additional, fully funded research programs targeting neurological disorders. Dr. Reyes is a highly accomplished biopharmaceutical executive who brings over 30 years of successful R&D leadership experience in major biotechnology and pharmaceutical companies. He has held senior leadership roles at Pfizer, Schering-Plough, and prior to joining Benitec Biopharma, Dr. Reyes held the position of Senior Vice President, Drug Discovery & Site Head at Celgene Corporation. Before joining Celgene Corporation, he was the Senior VP for Oncology Research and Development with Biogen Idec at their former San Diego campus.